Ongoing research aims to better understand the mechanisms of CAT and develop more effective prevention and treatment strategies. Studies are exploring the use of biomarkers to predict thrombosis risk and the efficacy of new anticoagulants. Additionally, researchers are investigating the genetic factors that may predispose certain cancer patients to thrombosis.
